Advertisement
IOVA vs VIR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Hold and VIR is a Hold.
IOVA in -2.40% downward trend, falling for three consecutive days on October 14, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IOVA declined for three days, in 282 of 323 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for IOVA moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 26 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IOVA as a result. In 77 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for IOVA turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 39 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
IOVA broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
Following a +13.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where IOVA advanced for three days, in 196 of 249 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 135 of 155 cases where IOVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. IOVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.887) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.370) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (12.484) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IOVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
VIR sees MACD Histogram crosses below signal line
VIR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 35 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIR as a result. In 69 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
VIR moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +6.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in 201 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
VIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 117 of 159 cases where VIR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. VIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.810) is normal, around the industry mean (26.782). P/E Ratio (6.398) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (5.168) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IOVA | VIR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 96 | |
PRICE GROWTH RATING 1..100 | 34 | 41 | |
P/E GROWTH RATING 1..100 | 100 | 22 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IOVA's Valuation (53) in the Biotechnology industry is in the same range as VIR (56) in the null industry. This means that IOVA’s stock grew similarly to VIR’s over the last 12 months.
IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VIR (100) in the null industry. This means that IOVA’s stock grew similarly to VIR’s over the last 12 months.
VIR's SMR Rating (96) in the null industry is in the same range as IOVA (97) in the Biotechnology industry. This means that VIR’s stock grew similarly to IOVA’s over the last 12 months.
IOVA's Price Growth Rating (34) in the Biotechnology industry is in the same range as VIR (41) in the null industry. This means that IOVA’s stock grew similarly to VIR’s over the last 12 months.
VIR's P/E Growth Rating (22) in the null industry is significantly better than the same rating for IOVA (100) in the Biotechnology industry. This means that VIR’s stock grew significantly faster than IOVA’s over the last 12 months.
| IOVA | VIR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | N/A |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 77% |
| Advances ODDS (%) | 8 days ago 79% | 16 days ago 75% |
| Declines ODDS (%) | 3 days ago 87% | 3 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IOVA’s FA Score shows that 0 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).
- IOVA’s FA Score: 0 green, 5 red.
- VIR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IOVA’s TA Score shows that 2 TA indicator(s) are bullish while VIR’s TA Score has 3 bullish TA indicator(s).
- IOVA’s TA Score: 2 bullish, 6 bearish.
- VIR’s TA Score: 3 bullish, 5 bearish.
Price Growth
IOVA (@Biotechnology) experienced а -6.84% price change this week, while VIR (@Biotechnology) price change was -14.87% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
IOVA is expected to report earnings on Nov 05, 2026.
VIR is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
IOVA and
Correlation & Price change
A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To IOVA | 1D Price Change % | ||
|---|---|---|---|---|
| IOVA | 100% | -7.47% | ||
| VCYT - IOVA | 43% Loosely correlated | -2.86% | ||
| VIR - IOVA | 39% Loosely correlated | -4.87% | ||
| NKTX - IOVA | 38% Loosely correlated | -6.74% | ||
| PLX - IOVA | 37% Loosely correlated | -2.96% | ||
| RXRX - IOVA | 36% Loosely correlated | -16.71% | ||
More | ||||
VIR and
Correlation & Price change
A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.
| Ticker / NAME | Correlation To VIR | 1D Price Change % | ||
|---|---|---|---|---|
| VIR | 100% | -4.87% | ||
| BEAM - VIR | 55% Loosely correlated | -5.10% | ||
| DNLI - VIR | 52% Loosely correlated | -3.98% | ||
| EDIT - VIR | 52% Loosely correlated | -3.69% | ||
| PRME - VIR | 51% Loosely correlated | -3.88% | ||
| RCUS - VIR | 51% Loosely correlated | -3.07% | ||
More | ||||